-
For a long time, I have thought that clinical trial information was too clinical to be of much use for patients who might be considering entering one. The information available was either in the form...
» Read more
-
Another week has zoomed by and we have already entered the second month of 2012 and yet in my head, it is still really the 1990s. Really. But for those of you who are in real time, it was an &he llip...
» Read more
-
Today Mashable carried a posting that quoted Dick Costolo, CEO of Twitter, as postulating that the election of 2012 would be the “Twitter Election“. Even people who do not participat e...
» Read more
-
It is the mildest winter I can remember. Today was slated to reach 60 degrees in Washington, D.C. No preparation of hot comfort foods, no roaring fires, no ice skating parties, no snow bal l...
» Read more
-
Every so often when I have giving a talk on social media I ask the audience how many of them are on Facebook. Usually nearly everyone in the audience raises a hand. Then I ask how many of them...
» Read more
-
You are sitting in the doctor’s office on that crinkly paper that pops every time you move. Your physician is leaning against a table and has just uttered some words that were a diagnosis. It...
» Read more
-
It’s that time of year – in the last 10 days I’ve received 2 different yellow pages directories found lying on my doorstep. Yellow pages advertising used to be the primary focus of m y...
» Read more
-
It has been a rather slow week for much interesting news – and so a twist to the Weekly Roundup this week. From time to time, I look to see what is going on with pharma and FDA in the … C ontinue...
» Read more
-
Anyone attending an FDA Advisory Committee meeting will likely discern right away that the job of serving in the capacity as a member is probably not terribly exciting. You have to travel from w here...
» Read more
-
With the mass success of the Apple iPhone and iPad, a lot of PC users have considered installing Apple Mac computers in their homes and offices...
» Read more